The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,950
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Sawyers, C. L. (2002) · Blood · doi:10.1182/blood.v99.10.3530 · Cited by 1,146
Modulation of Akt kinase activity by binding to Hsp90
Sato, S., Fujita, N., & Tsuruo, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170276797 · Cited by 967
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Seamon, K., & Daly, J. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68694-1 · Cited by 738
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
The biology of CML blast crisis
Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 592
Self-citationDissection of the protein kinase cascade by which nerve growth factor activates MAP kinases
Gómez, N., & Cohen, P. (1991) · Nature · doi:10.1038/353170a0 · Cited by 569
Fan, Z., Beresford, P. J., Oh, D. Y., Zhang, D., & Lieberman, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00150-8 · Cited by 541
Seo, S.-B., McNamara, P., Heo, S., Turner, A., Lane, W. S., & Chakravarti, D. (2001) · Cell · doi:10.1016/s0092-8674(01)00196-9 · Cited by 481
The Myeloid Leukemia-associated Protein SET Is a Potent Inhibitor of Protein Phosphatase 2A
Li, M., Makkinje, A., & Damuni, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11059 · Cited by 479
PP2A: the expected tumor suppressor
Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426
The BCR-ABL Story: Bench to Bedside and Back
Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 399
Cross, N. C. P., Feng, L., Chase, A., Bungey, J., Hughes, T., & Goldman, J. M. (1993) · Blood · doi:10.1182/blood.v82.6.1929.1929 · Cited by 365
Protein phosphatase 2A: the Trojan Horse of cellular signaling
Sontag, E. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00123-6 · Cited by 330
BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
Perrotti, D., Cesi, V., Trotta, R., Guerzoni, C., Santilli, G., Campbell, K., Iervolino, A., Condorelli, F., Gambacorti-Passerini, C., Caligiuri, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng791 · Cited by 313
Self-citationTenenbaum, S. (2002) · Methods · doi:10.1016/s1046-2023(02)00022-1 · Cited by 268
Control of protein phosphatase 2A by simian virus 40 small-t antigen.
Yang, S. I., Lickteig, R. L., Estes, R., Rundell, K., Walter, G., & Mumby, M. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1988 · Cited by 246
Kozlowski, M., Mlinaric-Rascan, I., Feng, G. S., Shen, R., Pawson, T., & Siminovitch, K. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2157 · Cited by 235
BCR/ABL activates mdm2 mRNA translation via the La antigen
Trotta, R., Vignudelli, T., Candini, O., Intine, R. V., Pecorari, L., Guerzoni, C., Santilli, G., Byrom, M. W., Goldoni, S., Ford, L. P., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00020-5 · Cited by 217
Self-citationMechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
Shah, N. P., & Sawyers, C. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206942 · Cited by 216
Cortez, D., Reuther, G., & Pendergast, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201400 · Cited by 216
Pathak, M. K., & Yi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3391 · Cited by 190
Role of serine/threonine protein phosphatase 2A in cancer
Schönthal, A. H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00561-4 · Cited by 186
Gaiger, A., Henn, T., Horth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., Greinix, H., Mannhalter, C., Haas, O., & Lechner, K. (1995) · Blood · doi:10.1182/blood.v86.6.2371.bloodjournal8662371 · Cited by 160
Fornerod, M. W. J., Boer, J. M., van Baal, S., Jaegle, M., Lindern, M. V., Murti, K. G., Davis, D. S., Bonten, J., Buijs, A., & Grosveld, G. C. (1995) · PubMed · Cited by 158
Jak2 is involved in c-Myc induction by Bcr-Abl
Xie, S., Lin, H., Sun, T., & Arlinghaus, R. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205942 · Cited by 156
Chiang, C.-W., Kanies, C. L., Kim, K. W., Fang, W. B., Parkhurst, C., Xie, M., Henry, T. J., & Yang, E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6350-6362.2003 · Cited by 155
Wang, G., Iakova, P. A., Wilde, M., Awad, S. S., & Timchenko, N. A. (2004) · Genes & Development · doi:10.1101/gad.1183304 · Cited by 154
Ding, X., & Staudinger, J. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076331 · Cited by 150
Perrotti, D., Bonatti, S., Trotta, R., Martinez, R., Skorski, T., Salomoni, P., Grassilli, E., Iozzo, R. V., Cooper, D. R., & Calabretta, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4442 · Cited by 132
Self-citationIervolino, A., Santilli, G., Trotta, R., Guerzoni, C., Cesi, V., Bergamaschi, A., Gambacorti-Passerini, C. B., Calabretta, B., & Perrotti, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2255-2266.2002 · Cited by 122
Self-citationAvni, D., Yang, H., Martelli, F., Hofmann, F., ElShamy, W. M., Ganesan, S., Scully, R., & Livingston, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00355-1 · Cited by 114
A novel cAMP-stimulated pathway in protein phosphatase 2A activation.
Feschenko, M., Stevenson, E., Nairn, A., & Sweadner, K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.111 · Cited by 114
Forskolin: A potential antimetastatic agent
Agarwal, K. C., & Parks, R. E. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910320622 · Cited by 100
Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.
Carlson, S. G., Eng, E., Kim, E. G., Perlman, E. J., Copeland, T. D., & Ballermann, B. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101873 · Cited by 90
Moon, E., & Lerner, A. (2003) · Blood · doi:10.1182/blood-2002-10-3208 · Cited by 79
Kamibayashi, C., Lickteig, R. L., Estes, R., Walter, G., & Mumby, M. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36692-x · Cited by 75
Elmaagacli, A. H., Beelen, D. W., Opalka, B., Seeber, S., & Schaefer, U. (2000) · Annals of Hematology · doi:10.1007/s002770000169 · Cited by 72
Lu, L., Welte, K., Gabrilove, J. L., et al. (1986) · PubMed · Cited by 69
Involvement of Protein Phosphatase 2A in the Interleukin-3-Stimulated Jak2-Stat5 Signaling Pathway
Yokoyama, N., Reich, N., & Miller, W. (2001) · Journal of Interferon and Cytokine Research · doi:10.1089/107999001750277844 · Cited by 54
Wera, S., Fernandez, A., Lamb, N. J. C., Turowski, P., Hemmings-Mieszczak, M., Mayer-Jaekel, R. E., & Hemmings, B. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21374 · Cited by 50
Saydam, G., Aydın, H. H., Şahin, F., Selvi, N., Öktem, G., Terzıoğlu, E., Büyükkeçeci, F., & Omay, S. B. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00347-8 · Cited by 46
BCR/ABL inhibition by an escort/phosphatase fusion protein
Lim, Y., Wong, S., Lau, G. Y.-F., Witte, O. N., & Colicelli, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210253497 · Cited by 43
Inhibition of Src by direct interaction with protein phosphatase 2A
Yokoyama, N. N., & Miller, W. T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02874-5 · Cited by 31
Gützkow, K. B., Naderi, S., & Blomhoff, H. K. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.1073 · Cited by 20
Cited by
Molecular biology of bcr-abl1–positive chronic myeloid leukemia
Quintás-Cardama, A., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2008-03-144790 · Cited by 745
CIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677
From Promiscuity to Precision: Protein Phosphatases Get a Makeover
Virshup, D. M., & Shenolikar, S. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.015 · Cited by 641
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Melo, J. V., & Barnes, D. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2147 · Cited by 623
Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.007 · Cited by 560
Self-citation
Metadata
- Authors
- Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H., Chang, J. S., Galietta, A., Uttam, A., Roy, D. C., Valtieri, M., Bruner-Klisovic, R., Caligiuri, M. A., Bloomfield, C. D., Marcucci, G., & Perrotti, D.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 8
- Issue
- 5
- Pages
- 355-368
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1981083415
- Cited by
- 476
- References
- 49
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.